Timelines of adverse event journeys of LVAD patients.
Timelines of adverse event journeys of LVAD patients.
复制标题
LVAD 患者不良事件经历的时间表。
DOI：
10.1111/aor.14596
复制
发表时间：
2023
影响因子：
2.4
通讯作者：
Antaki,JamesF
中科院分区：
文献类型：
--
作者：
Movahedi,Faezeh;Kanwar,ManreetK;Antaki,JamesF
INTERMACSEvents数据集包含了一个广泛的收集不良事件（AE）的过程中的时间证据，>15 000例患者接受了左心室辅助装置（LVAD）。AE的时间顺序可能包含LVAD患者“AE历程”的深刻信息。本研究的目的是调查INTERMACS database.MethodsDescriptive统计内的AE的时间表，应用于86 912记录的AE的15 820例患者的连续流-LVAD之间2008年至2016年，从INTERMACS注册表中提取。通过提出6个描述性研究问题，研究了AE旅程的时间线特征。ResultsThe分析揭示了LVAD后AE旅程的几个时间相关特征和模式，包括手术后AE发生的最常见时间、AE旅程的持续时间、首次和末次AE的时间、和AEs.ConclusionThe INTERMACS事件数据集是一个宝贵的资源，研究时间轴的AE旅程的患者谁收到LVAD。未来的研究有必要首先探索和考虑数据集的时间相关特征，如多样性和稀疏性，以有效地选择适当的时间范围和时间粒度，并认识到潜在的挑战。
ObjectiveThe INTERMACSEventsdata set contains an expansive collection of temporal evidence of the course of adverse events (AEs) of >15 000 patients that have received a left ventricular assist device (LVAD). The chronology of AEs may contain insightful information of the “AE journeys” of LVAD patients. The purpose of this study is to investigate the timelines of AEs within the INTERMACS database.MethodsDescriptive statistics were applied to 86 912 recorded AEs of 15 820 patients with a continuous flow‐LVAD between 2008 to 2016, extracted from INTERMACS registry. The characteristics of the timelines of AE journeys were investigated by posing six descriptive research questions.ResultsThe analysis revealed several time‐related characteristics and patterns of the AE journey after LVAD including the most common time of occurrences of AEs after surgery, duration of AEs journeys, the time of first and last AEs, and the time gaps between AEs.ConclusionThe INTERMACS Event dataset is a valuable resource for research about the timeline of AE journeys of patients who received an LVAD. It is necessary for future studies to first explore and consider the time‐related characteristics of the data set such as diversity and sparsity to effectively choose an appropriate scope of time and time granularity and to acknowledge potential challenges.